{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:14:03Z","timestamp":1786979643123,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[1997,11]]},"DOI":"10.1007\/s001250050821","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T03:30:30Z","timestamp":1030246230000},"page":"1278-1285","source":"Crossref","is-referenced-by-count":40,"title":["Effects of 4 weeks\u2019 administration of pramlintide, a human amylin analogue, on glycaemia control in patients with IDDM: effects on plasma glucose profiles and serum fructosamine concentrations"],"prefix":"10.1007","volume":"40","author":[{"given":"R. G.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. G.","family":"Kolterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"70401278125_CR1","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","volume":"84","author":"GSJ Cooper","year":"1989","unstructured":"Cooper GSJ, Willis AC, Clark A et al. (1989) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84: 8628\u20138632","journal-title":"Proc Natl Acad Sci USA"},{"key":"70401278125_CR2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF00404025","volume":"34","author":"E Hartter","year":"1991","unstructured":"Hartter E, Svoboda T, Ludvik B et al. (1991) Basal and stimulated plasma levels of pancreatic amylin indicate its cosecretion with insulin in humans. Diabetologia 34: 52\u201354","journal-title":"Diabetologia"},{"key":"70401278125_CR3","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2337\/diab.39.6.752","volume":"39","author":"PC Butler","year":"1990","unstructured":"Butler PC, Chou J, Carter B, Wang YN et al. (1990) Effects of meal ingestion on plasma amylin concentrations in NIDDM and nondiabetic humans. Diabetes 39: 752\u2013756","journal-title":"Diabetes"},{"key":"70401278125_CR4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0140-6736(92)90785-2","volume":"339","author":"JE Koda","year":"1992","unstructured":"Koda JE, Fineman M, Rink TJ, Dailey GE, Muchmore DB, Linarelli LG (1992) Amylin concentrations and glucose control. Lancet 339: 1179\u20131180","journal-title":"Lancet"},{"key":"70401278125_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-0495(97)90170-0","volume":"46","author":"BR Gedulin","year":"1997","unstructured":"Gedulin BR, Rink TJ, Young AA (1997) Dose-response for glucagonostatic effect of amylin in rats. Metabolism 46: 1\u20135","journal-title":"Metabolism"},{"issue":"1","key":"70401278125_CR6","doi-asserted-by":"crossref","first-page":"172 A","DOI":"10.2337\/diab.43.1.172","volume":"43","author":"K Brown","year":"1994","unstructured":"Brown K, Menius A, Sandefer E, Edwards J, James M (1994) The effects of amylin on changes in plasma glucose and gastric emptying following an oral glucose load in conscious dogs. Diabetes 43 [Suppl 1]: 172 A (Abstract)","journal-title":"Diabetes"},{"key":"70401278125_CR7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF00401833","volume":"38","author":"AA Young","year":"1995","unstructured":"Young AA, Gedulin B, Vine W, Percy A, Rink TJ (1995) Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin. Diabetologia 38: 642\u2013648","journal-title":"Diabetologia"},{"key":"70401278125_CR8","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/0006-291X(86)90708-4","volume":"140","author":"P Westermark","year":"1986","unstructured":"Westermark P, Wernstedt C, Wilander E, Sletten K (1986) A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140: 826\u2013831","journal-title":"Biochem Biophys Res Commun"},{"key":"70401278125_CR9","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2337\/diacare.18.8.1179","volume":"18","author":"OG Kolterman","year":"1995","unstructured":"Kolterman OG, Gottlieb A, Moyses C, Colburn W (1995) Reduction of postprandial hyperglycaemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue. Diabetes Care 18: 1179\u20131182","journal-title":"Diabetes Care"},{"key":"70401278125_CR10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/BF00400683","volume":"39","author":"OG Kolterman","year":"1996","unstructured":"Kolterman OG, Schwartz S, Corder C, Levy B, Klaff L, Peterson J, Gottlieb A (1996) Effect of 14 days subcutaneous administration of the human amylin analogue, pramlintide (AC 137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM. Diabetologia 39: 492\u2013499","journal-title":"Diabetologia"},{"key":"70401278125_CR11","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/biomet\/75.4.800","volume":"75","author":"Y Hochberg","year":"1988","unstructured":"Hochberg Y (1988) A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75: 800\u2013802","journal-title":"Biometrika"},{"key":"70401278125_CR12","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2337\/diabetes.46.4.632","volume":"46","author":"RG Thompson","year":"1997","unstructured":"Thompson RG, Peterson J, Gottlieb A, Mullane J (1997) Effects of pramlintide, a synthetic amylin analogue, on plasma glucose profiles in patients with insulin-dependent diabetes mellitus. Diabetes 46: 632\u2013636","journal-title":"Diabetes"},{"issue":"1","key":"70401278125_CR13","first-page":"A149","volume":"39","author":"MS Fineman","year":"1996","unstructured":"Fineman MS, Giotta MP, Thompson RG, Kolterman OG, Koda JE (1996) Amylin response following sustacal ingestion is diminished in type II diabetic patients treated with insulin. Diabetologia 39 [Suppl 1]: A149","journal-title":"Diabetologia"},{"key":"70401278125_CR14","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"DCCT Research Group","year":"1993","unstructured":"DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977\u2013986","journal-title":"N Engl J Med"},{"key":"70401278125_CR15","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2337\/diacare.18.11.1415","volume":"18","author":"The DCCT Research Group","year":"1995","unstructured":"The DCCT Research Group (1995) Adverse events and their association with treatment regimens in the diabetes control and complications trial. Diabetes Care 18: 1415\u20131427","journal-title":"Diabetes Care"},{"issue":"1","key":"70401278125_CR16","doi-asserted-by":"crossref","first-page":"A32","DOI":"10.1007\/BF02369367","volume":"38","author":"I MacDonald","year":"1995","unstructured":"MacDonald I, King P, Kong M-F, Stubbs T, Perkins A, Moyses, Tattersall R (1995) Infusion of the human amylin analogue, AC137, delays gastric emptying in men with IDDM. Diabetologia 38 [Suppl 1]: A32 (Abstract)","journal-title":"Diabetologia"},{"key":"70401278125_CR17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF00403371","volume":"37","author":"M Horowitz","year":"1994","unstructured":"Horowitz M, Fraser R (1994) Disordered gastric motor function in diabetes mellitus. Diabetologia 37: 543\u2013551","journal-title":"Diabetologia"},{"key":"70401278125_CR18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/gut.37.1.23","volume":"37","author":"TV Nowak","year":"1995","unstructured":"Nowak TV, Johnson CP, Kalbfleisch JH et al. (1995) Highly variable gastric emptying in patients with insulin dependent diabetes mellitus. Gut 37: 23\u201329","journal-title":"Gut"},{"key":"70401278125_CR19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/(SICI)1096-9136(199602)13:2<112::AID-DIA37>3.0.CO;2-H","volume":"13","author":"MFSC Kong","year":"1996","unstructured":"Kong MFSC, MacDonald IA, Tattersall RB (1996) Gastric emptying in diabetes. Diabet Med 13: 112\u2013119","journal-title":"Diabet Med"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s001250050821.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s001250050821\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s001250050821","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:54:12Z","timestamp":1558598052000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s001250050821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["70401278125"],"URL":"https:\/\/doi.org\/10.1007\/s001250050821","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}